Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Authors
Keywords
FDG, FET, MET, FDOPA, PET, Glioma
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-05
DOI
10.1007/s00259-018-4207-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- [ 18 F]Fluoroethyltyrosine–Positron Emission Tomography-Based Therapy Monitoring after Stereotactic Iodine-125 Brachytherapy in Patients with Recurrent High-Grade Glioma
- (2018) Nathalie L. Jansen et al. Molecular Imaging
- An insight into the EANM technologist committee benchmark document on nuclear medicine technologists’ competencies
- (2017) Pedro Fragoso Costa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical evaluation of TOF versus non-TOF on PET artifacts in simultaneous PET/MR: a dual centre experience
- (2017) Edwin E. G. W. ter Voert et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Static and dynamic 18F–FET PET for the characterization of gliomas defined by IDH and 1p/19q status
- (2017) Antoine Verger et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
- (2017) Egesta Lopci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET/MRI in the Presence of Metal Implants: Completion of the Attenuation Map from PET Emission Data
- (2017) Niccolo Fuin et al. JOURNAL OF NUCLEAR MEDICINE
- European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany
- (2017) D. L. Bailey et al. MOLECULAR IMAGING AND BIOLOGY
- Advances in neuro-oncology imaging
- (2017) Karl-Josef Langen et al. Nature Reviews Neurology
- Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma
- (2017) Bogdana Suchorska et al. NEURO-ONCOLOGY
- A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients
- (2017) Claes N. Ladefoged et al. NEUROIMAGE
- RESOLUTE PET/MRI Attenuation Correction for O-(2-18F-fluoroethyl)-L-tyrosine (FET) in Brain Tumor Patients with Metal Implants
- (2017) Claes N. Ladefoged et al. Frontiers in Neuroscience
- Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?
- (2017) Marcus Unterrainer et al. EJNMMI Research
- O-(2-[18F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres
- (2017) Christian P. Filss et al. EJNMMI Research
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- 18F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors
- (2016) Giovanni Morana et al. CLINICAL NUCLEAR MEDICINE
- Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18 F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic
- (2016) Markus Hutterer et al. JOURNAL OF NUCLEAR MEDICINE
- Dixon Sequence with Superimposed Model-Based Bone Compartment Provides Highly Accurate PET/MR Attenuation Correction of the Brain
- (2016) T. Koesters et al. JOURNAL OF NUCLEAR MEDICINE
- Amino acid PET for brain tumours — ready for the clinic?
- (2016) Karl-Josef Langen et al. Nature Reviews Neurology
- Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
- (2016) Nathalie L. Albert et al. NEURO-ONCOLOGY
- Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma
- (2016) Stefanie Bette et al. World Neurosurgery
- Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET
- (2015) S. Kebir et al. CLINICAL CANCER RESEARCH
- Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans
- (2015) Nathalie L. Albert et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dual-time-point O-(2-[18F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas
- (2015) Philipp Lohmann et al. EUROPEAN RADIOLOGY
- Segmentation-Based Attenuation Correction in Positron Emission Tomography/Magnetic Resonance
- (2015) Cornelia Brendle et al. INVESTIGATIVE RADIOLOGY
- The use of 18F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma
- (2015) J. W. Dankbaar et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?
- (2015) Norbert Galldiks et al. NEURO-ONCOLOGY
- Performance of18F-FET versus18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis
- (2015) Vincent Dunet et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- 18F-Fluorodeoxyglucose and 11C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas
- (2015) Hongyoon Choi et al. NUCLEAR MEDICINE COMMUNICATIONS
- Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
- (2014) J. Schwarzenberg et al. CLINICAL CANCER RESEARCH
- 11C-methinine uptake correlates with MGMT promoter methylation in nonenhancing gliomas
- (2014) Yoshiko Okita et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET
- (2014) Norbert Galldiks et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
- (2014) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Impact of imaging measurements on response assessment in glioblastoma clinical trials
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- PET in the Clinical Management of Glioma: Evidence Map
- (2013) Takashi Nihashi et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Validation of 18F-FDG PET at Conventional and Delayed Intervals for the Discrimination of High-Grade From Low-Grade Gliomas
- (2013) Koen Mertens et al. CLINICAL NUCLEAR MEDICINE
- Suggested pathway to assess radiation safety of 18F-labeled PET tracers for first-in-human studies
- (2013) Paolo Zanotti-Fregonara et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Molecular and metabolic pattern classification for detection of brain glioma progression
- (2013) Farzin Imani et al. EUROPEAN JOURNAL OF RADIOLOGY
- Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma
- (2013) N. Galldiks et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients
- (2013) K. Herrmann et al. NEURO-ONCOLOGY
- Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study
- (2013) D. H. Pafundi et al. NEURO-ONCOLOGY
- Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone
- (2013) Flemming Littrup Andersen et al. NEUROIMAGE
- 11C-Methionine Uptake Correlates with Combined 1p and 19q Loss of Heterozygosity in Oligodendroglial Tumors
- (2012) T. Saito et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
- (2012) T. Nihashi et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
- (2012) Norbert Galldiks et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
- (2012) N. Galldiks et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
- (2012) M. Rapp et al. JOURNAL OF NUCLEAR MEDICINE
- Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting
- (2012) Bernhard Sattler et al. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
- FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan
- (2012) C. Colavolpe et al. NEURO-ONCOLOGY
- Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas
- (2012) N. L. Jansen et al. NEURO-ONCOLOGY
- FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status
- (2012) Maximilian Niyazi et al. RADIOTHERAPY AND ONCOLOGY
- F-18 FDG PET-CT in patients with recurrent glioma: Comparison with contrast enhanced MRI
- (2011) Amburanjan Santra et al. EUROPEAN JOURNAL OF RADIOLOGY
- O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
- (2011) M. Hutterer et al. JOURNAL OF NUCLEAR MEDICINE
- High resolution BrainPET combined with simultaneous MRI
- (2011) H. Herzog et al. NUKLEARMEDIZIN-NUCLEAR MEDICINE
- Routine quality control recommendations for nuclear medicine instrumentation
- (2010) Ellinor Busemann Sokole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?
- (2010) Robert Pichler et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine and L-3H-Methionine Uptake in Cerebral Hematomas
- (2010) D. Salber et al. JOURNAL OF NUCLEAR MEDICINE
- Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme
- (2009) Norbert Galldiks et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
- (2009) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
- (2009) Andrea Varrone et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Transient Focal Increase in Perihematomal Glucose Metabolism After Acute Human Intracerebral Hemorrhage
- (2009) Allyson R. Zazulia et al. STROKE
- Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy
- (2008) Y. Terakawa et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started